Benralizumab for the prevention of COPD exacerbations

Benralizumab for the prevention of COPD exacerbations

<p><h4>BACKGROUND</h4></p> <p>The efficacy and safety of benralizumab, an interleukin-5 receptor alpha–directed cytolytic monoclonal antibody, for the prevention of exacerbations in patients with moderate to very severe chronic obstructive pulmonary disease (COPD) are n...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Criner, G, Celli, B, Brightling, C, Agusti, A, Papi, A, Singh, D, Sin, D, Vogelmeier, C, Sciurba, F, Bafadhel, M, Backer, V, Kato, M, Ramírez-Venegas, A, Wei, Y, Bjermer, L, Shih, V, Jison, M, O'Quinn, S, Makulova, N, Newbold, P, Goldman, M, Martin, U, Galathea and Terranova Study Investigators
Định dạng: Journal article
Ngôn ngữ:English
Được phát hành: Massachusetts Medical Society 2019

Những quyển sách tương tự